RA Capital Management »

Scilex Holding shares owned by RA Capital Management

Quarter-by-quarter ownership of Scilex Holding (SCLX) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Scilex Holding

Tip: Access up to 7 years of quarterly data

All positions including Scilex Holding held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scilex Holding by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $504k 261k 1.93

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Biogen SH (BIIB)
Eliem Therapeutics SH (ELYM)
Rxsight SH (RXST)
Avidity Biosciences SH (RNA)
Dyne Therapeutics SH (DYN)
Geron Corp SH (GERN)
Pepgen SH (PEPG)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)

View all positions for RA Capital Management

Top funds holding Scilex Holding

Armistice Capital
State Street Corporation
BlackRock
Vanguard Group
Geode Capital Management
Northern Trust
D. E. Shaw & Co
Rafferty Asset Management
Henderson Group
Jpmorgan Chase & Co
Jane Street
RA Capital Management
Millennium Management
Laurion Capital Management
CVI Holdings

View all funds holding Scilex Holding